IndraLab

Statements



No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

reach
"The inhibition of p65 signaling by the NF-κB inhibitor pyrrolidine dithiocarbamate or recombinant lentiviral vector-p65 small interfering RNA (LV-p65 siRNA) remarkably attenuated diabetic neuropathic pain."

reach
"Compared to the group with palmitate treatment alone, pyrrolidine dithiocarbamic acid (10/20 micromol/L) significantly inhibited the palmitate induced increase of p-NF-kappaB p65 (1.39 +/- 0.12, 1.25 +/- 0.10 vs 1.76 +/- 0.14, both P < 0.05), restored the palmitate induced decrease of caspase-3 (2.24 +/- 0.28 vs 1.29 +/- 0.27, P < 0.05) and inhibited the palmitate induced increase of cleaved caspase-3 (0.63 +/- 0.01 vs 1.13 +/- 0.10, P < 0.05)."

No evidence text available